Skip to content

Neurology · Migraine

Migraine Prevention: New Options Worth Asking Your Doctor About

Torii Health article cover

If migraines are costing you several days every month, you may not have to just ride them out. A newer group of preventive medications is now recommended as a first choice, and your primary care doctor can usually start one without a long wait for a specialist.

Why This Matters

Migraine affects about 57 million people in the US. It is two to three times more common in women, who also tend to have longer attacks, more disability, and slower recovery. Men are less likely to seek care, often have less typical symptoms, and are more often misdiagnosed. They have also been left out of much of the research: roughly 80% of trial participants have been women.

Many people assume migraine prevention means waiting to see a neurologist. In the US, that wait can run three to nine months or longer, and finding an English-speaking specialist here in Japan can add another hurdle. The good news is that some of the most effective prevention options today are well within what your primary care doctor can offer.

What the Latest Guidance Says

In 2024, the American Headache Society updated its position: medications that target a protein called CGRP are now considered a first choice for preventing migraine in adults, not a last resort after everything else has failed.

CGRP (calcitonin gene-related peptide) is a protein in the nervous system that widens blood vessels and plays a central role in setting off a migraine. Blocking it can mean fewer attacks to begin with, rather than just treating each one after it starts.

Count headache days, not headaches

Prevention is worth discussing if you have four or more headache days a month that slow you down at all, five or more migraine days a month even without much impact, or three or more migraine days a month that knock you out completely. One attack that lasts two days counts as two days, and every kind of headache counts toward the total, not just migraines.

The Newer Options and How They Compare

Two kinds of medication target CGRP. They work in slightly different ways, but the results are similar:

Because the injections and tablets perform about equally well, the choice usually comes down to what your insurance covers and what fits your life best. One practical note: atogepant interacts with a number of other medications, so make sure your doctor sees your full medication and supplement list.

The catch: cost

None of these medications come in a generic version yet. In the US, manufacturer savings programs can bring the monthly cost way down, sometimes to almost nothing. Coverage and availability for patients living in Japan can work differently, so this is a good thing to sort out with us before you start. See how we handle insurance and billing.

If Medication Alone Isn't Enough

Medication works best alongside other tools. Acupuncture carries the strongest possible recommendation (grade A) from the American Academy of Family Physicians for preventing frequent migraine. Cognitive behavioral therapy, mindfulness, and relaxation training also help. So do the basics: staying hydrated, drinking less alcohol, keeping caffeine moderate, sleeping enough, and noticing triggers like harsh lighting, loud noise, or strong smells. Some people also find green light therapy soothing during an attack.

If everything within primary care has been tried, that is the time to see a neurologist. Specialists can offer Botox injections (about 31 small injections across the head and neck every three months), nerve blocks, and several wearable or handheld nerve stimulation devices. We can help coordinate a specialist referral when it's time.

A Few Things Worth Keeping in Mind

What You Can Actually Do

The bottom line: If headaches are taking four or more days a month from you, prevention is worth a conversation. Newer medications that target CGRP are now a recommended first choice, about half of people cut their migraine days in half within three months, and your primary care doctor can usually get you started without waiting months for a specialist.

You don't have to keep losing days to migraines. Bring your headache log in, and we'll build a prevention plan that fits your life.

Portrait of Dr. Kenji Taylor, MD

Partnering in your care,

Dr. Kenji Taylor, MD

Torii Health & Iris Dental and Medical

Sources

Adapted from “Migraine Prevention: What Actually Works” by Michael Baca-Atlas, MD, and Michael McCarthy, PA-C.

  1. Cohen F, Brooks CV, Sun D, et al. Prevalence and burden of migraine in the United States: a systematic review. Headache. 2024;64(5):516-532. PubMed
  2. Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: updated age, sex, and socioeconomic-specific estimates from government health surveys. Headache. 2021;61(1):60-68. PubMed
  3. Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16(1):76-87. PubMed
  4. Fitzek MP, Boucherie DM, de Vries T, et al. Migraine in men. J Headache Pain. 2025;26(1):3. PubMed
  5. Charles AC, Digre KB, et al. Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: an American Headache Society position statement update. Headache. 2024;64(4):333-341. PubMed
  6. Ailani J, Burch RC, Robbins MS. The American Headache Society consensus statement: update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021-1039. PubMed
  7. Qaseem A, Cooney TG, Etxeandia-Ikobaltzeta I, et al. Prevention of episodic migraine headache using pharmacologic treatments in outpatient settings: a clinical guideline from the American College of Physicians. Ann Intern Med. 2025;178(3):426-433. PubMed
  8. Moreland P, Gaffney B, Lanham JS. Migraine headache prophylaxis. Am Fam Physician. 2025;111(5):443-450. PubMed
  9. Treadwell JR, Tsou AY, Rouse B, et al. Behavioral interventions for migraine prevention: a systematic review and meta-analysis. Headache. 2025;65(4):668-694. PubMed
  10. Seng EK, Martin PR, Houle TT. Lifestyle factors and migraine. Lancet Neurol. 2022;21(10):911-921. PubMed
  11. Department of Veterans Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Headache. Version 1.0. September 2023.
  12. Robbins MS. Diagnosis and management of headache: a review. JAMA. 2021;325(18):1874-1885. PubMed
  13. Ashina M, Buse DC, Ashina H, et al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet. 2021;397(10283):1505-1518. PubMed
  14. Ashina M. Migraine. N Engl J Med. 2020;383(19):1866-1876. PubMed
  15. Dodick DW. Migraine. Lancet. 2018;391(10127):1315-1330. PubMed
  16. Schwedt TJ, Starling AJ, Ailani J, et al. Routine migraine screening as a standard of care for women's health: a position statement from the American Headache Society. Headache. 2026;66(2):511-516. PubMed
  17. GBD 2023 Headache Collaborators. Global, regional, and national burden of headache disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Neurol. 2025;24(12):1005-1015. PubMed

Have a question or comment?

We value your input! Share your thoughts on our latest issue or ask a question you'd like us to cover in a future article.

Ask a question

Losing days to migraines?

We'll review your headache pattern and walk through prevention options together. We direct bill AFSPA, BCBS, Cigna, and Tricare right here in Japan (Tricare Prime requires a referral).